Loading...
Zai Lab Limited
9688.HK•HKSE
HealthcareBiotechnology
HK$29.65
HK$1.10(3.85%)
Zai Lab Limited (9688.HK) Financial Performance & Statements
Review Zai Lab Limited’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
49.59%
↑ 49.59%
Operating Income Growth
23.04%
↑ 23.04%
Net Income Growth
23.17%
↑ 23.17%
Operating Cash Flow Growth
-8.42%
↓ 8.42%
Operating Margin
-64.09%
↓ 64.09%
Gross Margin
63.45%
↑ 63.45%
Net Profit Margin
-60.26%
↓ 60.26%
ROE
-33.35%
↓ 33.35%
ROIC
-31.41%
↓ 31.41%
Zai Lab Limited (9688.HK) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Zai Lab Limited stock.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $109.07M | $102.27M | $100.50M | $87.15M |
| Cost of Revenue | $42.09M | $36.92M | $35.23M | $33.62M |
| Gross Profit | $66.98M | $65.35M | $65.27M | $53.53M |
| Gross Profit Ratio | $0.61 | $0.64 | $0.65 | $0.61 |
| R&D Expenses | $52.25M | $65.98M | $61.63M | $54.65M |
| SG&A Expenses | $82.62M | $67.22M | $79.71M | $69.19M |
| Operating Expenses | $134.87M | $133.20M | $172.32M | $123.84M |
| Total Costs & Expenses | $176.96M | $170.12M | $176.57M | $157.46M |
| Interest Income | $9.09M | $9.03M | $9.33M | $9.66M |
| Interest Expense | $904000.00 | $745000.00 | $492000.00 | $113000.00 |
| Depreciation & Amortization | $3.03M | $2.87M | $2.94M | $3.01M |
| EBITDA | -$77.75M | -$38.05M | -$76.84M | -$50.35M |
| EBITDA Ratio | -$0.71 | -$0.37 | -$0.76 | -$0.58 |
| Operating Income | -$67.89M | -$67.85M | -$76.06M | -$70.31M |
| Operating Income Ratio | -$0.62 | -$0.66 | -$0.76 | -$0.81 |
| Other Income/Expenses (Net) | -$13.79M | $26.18M | -$4.21M | $16.84M |
| Income Before Tax | -$81.68M | -$41.67M | -$80.28M | -$53.47M |
| Income Before Tax Ratio | -$0.75 | -$0.41 | -$0.80 | -$0.61 |
| Income Tax Expense | $0.00 | $0.00 | $0.00 | $9.47M |
| Net Income | -$81.68M | -$41.67M | -$80.28M | -$53.47M |
| Net Income Ratio | -$0.75 | -$0.41 | -$0.80 | -$0.61 |
| EPS | -$0.08 | -$0.43 | -$0.82 | -$0.55 |
| Diluted EPS | -$0.08 | -$0.43 | -$0.82 | -$0.55 |
| Weighted Avg Shares Outstanding | $1.03B | $97.59M | $97.59M | $97.31M |
| Weighted Avg Shares Outstanding (Diluted) | $1.03B | $97.59M | $97.59M | $97.31M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan